Pulse Biosciences Inc
NASDAQ:PLSE
Pulse Biosciences Inc
Additional Paid In Capital
Pulse Biosciences Inc
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pulse Biosciences Inc
NASDAQ:PLSE
|
Additional Paid In Capital
$383.3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Additional Paid In Capital
$20.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
Stryker Corp
NYSE:SYK
|
Additional Paid In Capital
$2.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Additional Paid In Capital
$8.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Additional Paid In Capital
$586m
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
See Also
What is Pulse Biosciences Inc's Additional Paid In Capital?
Additional Paid In Capital
383.3m
USD
Based on the financial report for Mar 31, 2024, Pulse Biosciences Inc's Additional Paid In Capital amounts to 383.3m USD.
What is Pulse Biosciences Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
21%
Over the last year, the Additional Paid In Capital growth was 30%. The average annual Additional Paid In Capital growth rates for Pulse Biosciences Inc have been 22% over the past three years , 21% over the past five years .